Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization tastatic breast cancer treated with trastuzumab
Allan Lipton, Wolfgang J. Köstler, Kim Leitzel, Suhail M. Ali, Jeff Sperinde, Jodi Weidler, Agnes Paquet, Thomas Sherwood, Weidong Huang, Michael Bates
Dive into the research topics of 'Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization tastatic breast cancer treated with trastuzumab'. Together they form a unique fingerprint.